OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 66 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 4.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $47,000 | -29.9% | 108,358 | -9.3% | 0.00% | 0.0% |
| Q1 2016 | $67,000 | -70.5% | 119,482 | -9.4% | 0.00% | -66.7% |
| Q4 2015 | $227,000 | +2.3% | 131,860 | +25.1% | 0.00% | 0.0% |
| Q3 2015 | $222,000 | -60.3% | 105,404 | -6.7% | 0.00% | -62.5% |
| Q2 2015 | $559,000 | -42.1% | 112,965 | -8.4% | 0.01% | -27.3% |
| Q1 2015 | $966,000 | +47.7% | 123,361 | +14.3% | 0.01% | +37.5% |
| Q4 2014 | $654,000 | +37.4% | 107,882 | -3.5% | 0.01% | +33.3% |
| Q3 2014 | $476,000 | -39.5% | 111,815 | -12.2% | 0.01% | -40.0% |
| Q2 2014 | $787,000 | -32.8% | 127,312 | -29.4% | 0.01% | -33.3% |
| Q1 2014 | $1,172,000 | +300.0% | 180,231 | +246.3% | 0.02% | +275.0% |
| Q4 2013 | $293,000 | -49.6% | 52,045 | -45.0% | 0.00% | -71.4% |
| Q3 2013 | $581,000 | +38.7% | 94,547 | +31.9% | 0.01% | +75.0% |
| Q2 2013 | $419,000 | – | 71,687 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |